Liver Transplant

Liver transplantation is a life-saving surgery for the treatment of suitable patients with end-stage liver disease and some types of liver cancer.¹

Both living-donor and deceased-donor liver transplants are possible.²

The outcome of liver transplantation has markedly improved over the last three decades.³ With current immunosuppression regimens, the rate of acute rejection after liver transplantation is low.³ Chronic rejection is also very uncommon.³

Immunosuppressive medication is one of the most important factors in the treatment outcome for liver transplant patients.¹ 

Nonadherence to immunosuppressive therapy after transplantation affects the success of the transplant and the survival of patients, yet 15–40% of patients do not take their immunosuppressive medications regularly.¹ This is one of the leading causes of liver transplant failure.¹

Whilst various complex factors play a role in non-compliance with post-organ-transplant immunotherapy, cost is one of the possible issues.⁴ Immunotherapy medications are a major component of total expenditure after organ transplantation,⁴ which is why high-quality generic post-transplant immunotherapy medications are needed.

Sandoz and Novartis have over 40 years of experience in transplant care and Sandoz is the #1 provider of generic transplant medications in Europe.⁵ We are proud of our ability to help patients maintain the optimum immunosuppression medication dosing which is so critical to transplant care.⁵